Dabigatran versus warfarin in patients with atrial fibrillation SJ Connolly, MD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, A Parekh, ... New England journal of medicine 361 (12), 1139-1151, 2009 | 14475 | 2009 |
Eplerenone in patients with systolic heart failure and mild symptoms F Zannad, JJV McMurray, H Krum, DJ van Veldhuisen, K Swedberg, H Shi, ... New England Journal of Medicine 364 (1), 11-21, 2011 | 3736 | 2011 |
Apixaban in patients with atrial fibrillation SJ Connolly, J Eikelboom, C Joyner, HC Diener, R Hart, S Golitsyn, ... New England Journal of Medicine 364 (9), 806-817, 2011 | 3402 | 2011 |
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study K Swedberg, M Komajda, M Böhm, JS Borer, I Ford, A Dubost-Brama, ... The Lancet 376 (9744), 875-885, 2010 | 3377 | 2010 |
Cholesterol lowering in intermediate-risk persons without cardiovascular disease S Yusuf, J Bosch, G Dagenais, J Zhu, D Xavier, L Liu, P Pais, ... New England Journal of Medicine 374 (21), 2021-2031, 2016 | 1029 | 2016 |
Tiotropium versus salmeterol for the prevention of exacerbations of COPD C Vogelmeier, B Hederer, T Glaab, H Schmidt, MPMH Rutten-van Mölken, ... New England Journal of Medicine 364 (12), 1093-1103, 2011 | 968 | 2011 |
Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis SE Nissen, ND Yeomans, DH Solomon, TF Lüscher, P Libby, ME Husni, ... New England Journal of Medicine 375, 2519-2529, 2016 | 915 | 2016 |
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease EM Lonn, J Bosch, P López-Jaramillo, J Zhu, L Liu, P Pais, R Diaz, ... New England Journal of Medicine 374 (21), 2009-2020, 2016 | 805 | 2016 |
Ivabradine in stable coronary artery disease without clinical heart failure K Fox, I Ford, PG Steg, JC Tardif, M Tendera, R Ferrari New England Journal of Medicine 371 (12), 1091-1099, 2014 | 628 | 2014 |
Blood-pressure and cholesterol lowering in persons without cardiovascular disease S Yusuf, E Lonn, P Pais, J Bosch, P Lopez-Jaramillo, J Zhu, D Xavier, ... New England Journal of Medicine 374 (21), 2032-2043, 2016 | 497 | 2016 |
Bempedoic acid and cardiovascular outcomes in statin-intolerant patients SE Nissen, AM Lincoff, D Brennan, KK Ray, D Mason, JJP Kastelein, ... New England Journal of Medicine 388 (15), 1353-1364, 2023 | 446 | 2023 |
Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial HC Diener, J Eikelboom, SJ Connolly, CD Joyner, RG Hart, GYH Lip, ... The Lancet Neurology 11 (3), 225-231, 2012 | 233 | 2012 |
Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment M Nowicki, I Rychlik, H Haller, ML Warren, L Suchower, I Gause‐Nilsson, ... Diabetes, Obesity and Metabolism 13 (6), 523-532, 2011 | 176 | 2011 |
European Guideline on IgG4-related digestive disease–UEG and SGF evidence-based recommendations JM Löhr, U Beuers, M Vujasinovic, D Alvaro, JB Frøkjær, F Buttgereit, ... United European gastroenterology journal 8 (6), 637-666, 2020 | 168 | 2020 |
A dose-dependent improvement in exercise tolerance in patients with stable angina treated with mildronate: a clinical trial “MILSS I” V Dzerve, mIlSS I Study group Medicina 47 (10), 78, 2011 | 116 | 2011 |
Effects of blood pressure and lipid lowering on cognition: results from the HOPE-3 study J Bosch, M O'Donnell, B Swaminathan, EM Lonn, M Sharma, G Dagenais, ... Neurology 92 (13), e1435-e1446, 2019 | 72 | 2019 |
Место тиотриазолина в галерее современных метаболитотропных лекарственных средств ИФ Беленичев, ВА Визир, ВИ Мамчур, АВ Курята Запорожский медицинский журнал, 118-128, 2019 | 37* | 2019 |
Prospective multicenter study of HX575 (biosimilar epoetin-α) in patients with chronic kidney disease applying a target hemoglobin of 10--12 g/dl. WH Hörl, F Locatelli, M Haag-Weber, M Ode, K Roth Clinical nephrology 78 (1), 24-32, 2012 | 36 | 2012 |
Эндотелиальная дисфункция при сердечной недостаточности с сохраненной систолической функцией и ее коррекция препаратом метаболического ряда милдронатом ВП Гейченко, АВ Курята, ОВ Мужчиль Российский кардиологический журнал, 68-71, 2005 | 31 | 2005 |
Возможности использования метаболического корректора милдроната в комплексном лечении хронической сердечной недостаточности с сохраненной систолической функцией ВП Гейченко, АВ Курята, ОВ Мужчиль Медицина неотложных состояний 8 (1), 73-78, 2007 | 25 | 2007 |